Psychiatric symptoms in Parkinson's disease.

被引：6

作者：

Anderson K.E. ^{[1
]}

Weiner W.J. ^{[1
]}

机构：

[1] Department of Neurology, Movement Disorders, University of Maryland, School of Medicine, 22 South Greene Street, Baltimore, 21201, MD

来源：

Current Neurology and Neuroscience Reports | 2002年 / 2卷 / 4期

关键词：

Clozapine; Anxiety Disorder; Risperidone; Olanzapine; Quetiapine;

D O I：

10.1007/s11910-002-0005-6

中图分类号：

学科分类号：

摘要：

Aside from the well-known triad of resting tremor, postural instability, and bradykinesia, Parkinson's disease (PD) patients may also develop psychiatric illness as a part of their disease. The psychiatric symptoms may be as disabling as the movement disorder, but are often amenable to treatment. We review the most recent investigations of mood disorders, anxiety disorders, and hallucinations/ psychosis in PD. We then highlight new treatment studies for hallucinations/psychosis in PD.

引用

页码：303 / 309

页数：6

共 50 条

[11] Avoid olanzapine in Parkinson's disease? [J].

Reactions Weekly, 2000, 829 (1) :4-4

[12] Management of delirium in Parkinson's disease [J].

Ebersbach, Georg ;

Ip, Chi Wang ;

Klebe, Stephan ;

Koschel, Jiri ;

Lorenzl, Stefan ;

Schrader, Christoph ;

Winkler, Christian ;

Franke, Christiana .

JOURNAL OF NEURAL TRANSMISSION, 2019, 126 (07) :905-912

[13] Treatment of drug-induced psychosis in patients with Parkinson's disease. [J].

Lublin, H .

NORDIC JOURNAL OF PSYCHIATRY, 1997, 51 :57-63

[14] On the Optimal Diagnosis and the Evolving Role of Pimavanserin in Parkinson's Disease Psychosis [J].

Pagan, Fernando L. ;

Schulz, Paul E. ;

Torres-Yaghi, Yasar ;

Pontone, Gregory M. .

CNS DRUGS, 2024, 38 (05) :333-347

[15] An exploratory study of the efficacy and safety of yokukansan for neuropsychiatric symptoms in patients with Parkinson's disease [J].

Hatano, Taku ;

Hattori, Nobutaka ;

Kawanabe, Tadaaki ;

Terayama, Yasuo ;

Suzuki, Norihiro ;

Iwasaki, Yasuo ;

Fujioka, Toshiki .

JOURNAL OF NEURAL TRANSMISSION, 2014, 121 (03) :275-281

[16] Quetiapine improves psychotic symptoms and cognition in Parkinson's disease [J].

Juncos, JL ;

Roberts, VJ ;

Evatt, ML ;

Jewart, RD ;

Wood, CD ;

Potter, LS ;

Jou, HC ;

Yeung, PP .

MOVEMENT DISORDERS, 2004, 19 (01) :29-35

[17] Parkinson's disease: the treatment of drug-induced hallucinations and psychosis. [J].

Molho E.S. ;

Factor S.A. .

Current Neurology and Neuroscience Reports, 2001, 1 (4) :320-328

[18] A comparative study of olanzapine, aripiprazole and risperidone in the treatment of psychiatric and behavioral symptoms of Alzheimer's disease [J].

Zhu, Liang ;

Wu, Guanjin ;

Heng, Weiwei ;

Zang, Xuefeng .

PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 34 (05) :2053-2057

[19] D-serine adjuvant treatment alleviates behavioural and motor symptoms in Parkinson's disease [J].

Gelfin, Evgenia ;

Kaufman, Yakir ;

Korn-Lubetzki, Isabelle ;

Bloch, Boaz ;

Kremer, Ilana ;

Javitt, Daniel C. ;

Heresco-Levy, Uriel .

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 (04) :543-549

[20] Risperidone and the Treatment of Psychiatric, Motor, and Cognitive Symptoms in Huntington's Disease [J].

Duff, Kevin ;

Beglinger, Leigh J. ;

O'Rourke, Margaret E. ;

Nopoulos, Peg ;

Paulson, Henry L. ;

Paulsen, Jane S. .

ANNALS OF CLINICAL PSYCHIATRY, 2008, 20 (01) :1-3

← 1 2 3 4 5 →